Literature DB >> 24631861

cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells.

Nirav Khatri1, Dipesh Baradia1, Imran Vhora1, Mohan Rathi1, Ambikanandan Misra2.   

Abstract

Development of effective vector for intracellular delivery of siRNA has always been a challenge due to its hydrophilicity, net negative surface charge and sensitivity against nucleases in biological milieu. The present investigation was aimed to develop a novel non-viral liposomal carrier for siRNA delivery. Nano-precipitate of calcium phosphate was entrapped in liposomes composed of a neutral lipid (DPPC), a fusogenic lipid (DOPE), a PEGylated lipid (DSPE-mPEG2000) and cholesterol. siRNA was made permeable through liposomal bilayer and complexed to calcium phosphate precipitates inside the liposomes. siRNA entrapped liposomes were further grafted with cRGD to achieve targeting potential against cancer cells. More than 80% of siRNA was entrapped inside the liposomes having average particle size below 150nm. Cryo-transmission electron microscopy revealed the intra-liposomal calcium phosphate precipitation and unilamellar morphology of prepared liposomes. The viability of A549 lung cancer cells was significantly higher after treatment with siRNA entrapped liposomes as compared to Lipofectamine2000 complexed siRNA. Fluorescent intensity in lung carcinoma cells was significantly higher after exposure to fluorescent siRNA entrapped liposomes than with Lipofectamine2000, which were confirmed by both confocal microscopy and flow cytometry. Live imaging by confocal microscopy ascertained the targeting efficacy of cRGD grafted liposomes compared to naked siRNA and non-grafted liposomes. Developed liposomal formulation showed effective protection of siRNA against serum nucleases along with less haemolytic potential and excellent stability against electrolyte induced flocculation. At 5nM concentration gene expression of target protein was reduced up to 24.1±3.4% while Lipofectamine2000 reduced expression level up to 26.35±1.55%. In vivo toxicity in mice suggested admirable safety profile for developed lipid based delivery vector. These results advocate that prepared liposomal system would be of high value for intracellular delivery of siRNA.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium phosphate; Liposome; Nano-precipitate; cRGD; siRNA

Mesh:

Substances:

Year:  2014        PMID: 24631861     DOI: 10.1016/j.jconrel.2014.03.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

Review 1.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

2.  Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.

Authors:  Nirav Khatri; Dipesh Baradia; Imran Vhora; Mohan Rathi; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2014-08-22       Impact factor: 3.246

Review 3.  Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.

Authors:  Janel Kydd; Rahul Jadia; Praveena Velpurisiva; Aniket Gad; Shailee Paliwal; Prakash Rai
Journal:  Pharmaceutics       Date:  2017-10-14       Impact factor: 6.321

Review 4.  Recent Advances in Nanomaterials for Gene Delivery-A Review.

Authors:  Michael K Riley; Wilfred Vermerris
Journal:  Nanomaterials (Basel)       Date:  2017-04-28       Impact factor: 5.076

5.  Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin.

Authors:  Yan Zou; Jingjing Wei; Yifeng Xia; Fenghua Meng; Jiandong Yuan; Zhiyuan Zhong
Journal:  Signal Transduct Target Ther       Date:  2018-12-14

Review 6.  Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA.

Authors:  Xuemei Ge; Lijuan Chen; Bo Zhao; Weien Yuan
Journal:  Front Pharmacol       Date:  2021-01-20       Impact factor: 5.810

Review 7.  Calcium phosphate nanoparticles-based systems for siRNA delivery.

Authors:  Xiaochun Xu; Zehao Li; Xueqin Zhao; Lawrence Keen; Xiangdong Kong
Journal:  Regen Biomater       Date:  2016-03-04

8.  A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.

Authors:  Cheng-Xiang Zhang; Wei-Yu Zhao; Lei Liu; Rui-Jun Ju; Li-Min Mu; Yao Zhao; Fan Zeng; Hong-Jun Xie; Yan Yan; Wan-Liang Lu
Journal:  Oncotarget       Date:  2015-10-20

9.  A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy.

Authors:  Mingxiang Cai; Li Yang; Shufan Zhang; Jiafan Liu; Yao Sun; Xiaogang Wang
Journal:  Int J Nanomedicine       Date:  2017-10-13

Review 10.  [Application of target peptide in siRNA delivery 
for the research of lung cancer therapy].

Authors:  Honglin Gao; Jianfeng Liu; Naling Song
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.